Conestoga Capital Advisors, an asset management company, released its first-quarter 2026 investor letter. A copy of the letter is available to download here. The first quarter of 2026 started with optimism about the domestic economy and attractive small-cap valuations, but it was affected by volatility due to geopolitical unrest in the Middle East and shifting expectations regarding interest rates. This unrest drove up energy prices and created a cautious global market. Energy, Basic Materials, and Industrials performed well, while software companies faced challenges due to AI disruption concerns. Market sensitivity to geopolitical events, energy prices, and inflation remains high. The Conestoga Smid Cap Composite fell 10.24% net-of-fees, underperforming the Russell 2500 Growth Index’s -3.52% return. The decline was driven by negative stock selection and sector/industry-specific headwinds, notably within Technology, Industrials, and Health Care sectors. In addition, please check the Strategy’s top five holdings to know its best picks in 2026.
In its first-quarter 2026 investor letter, Conestoga Capital Advisors highlighted Balchem Corporation (NASDAQ:BCPC) as a notable contributor. Balchem Corporation (NASDAQ:BCPC) is a specialty chemicals company that serves nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets. On May 5, 2026, Balchem Corporation (NASDAQ:BCPC) closed at $161.13 per share. One-month return of Balchem Corporation (NASDAQ:BCPC) was -7.42%, and its shares lost 1.75% over the past 52 weeks. Balchem Corporation (NASDAQ:BCPC) has a market capitalization of $5.18 billion.
Conestoga Capital Advisors stated the following regarding Balchem Corporation (NASDAQ:BCPC) in its Q1 2026 investor letter:
“Balchem Corporation (NASDAQ:BCPC) provides specialty ingredients and nutrition solutions across food, pharma, and animal health markets. The quarter highlighted the durability of the model, with steady growth across segments and continued alignment with “better-for-you” consumer trends. Earnings growth remained consistent, with net income increasing nearly 17%, reflecting both pricing and favorable mix. In a more uncertain market, investors gravitated toward BCPC’s ability to compound earnings with relatively low volatility.”
Balchem Corporation (NASDAQ:BCPC) is not on our list of 40 Most Popular Stocks Among Hedge Funds Heading Into 2026. According to our database, 32 hedge fund portfolios held Balchem Corporation (NASDAQ:BCPC) at the end of the fourth quarter, up from 31 in the previous quarter. In the first quarter of 2026, Balchem Corporation (NASDAQ:BCPC) reported record quarterly consolidated revenue of $271 million, marking an increase of 8.1% compared to the prior year quarter. While we acknowledge the risk and potential of Balchem Corporation (NASDAQ:BCPC) as an investment, our conviction lies in the belief that some AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than Balchem Corporation (NASDAQ:BCPC) and that has 10,000% upside potential, check out our report about this cheapest AI stock.
In addition, please check out our hedge fund investor letters Q1 2026 page for more investor letters from hedge funds and other leading investors.
READ NEXT: 33 Stocks That Should Double in 3 Years and 15 Stocks That Will Make You Rich in 10 Years.
Disclosure: None. This article is originally published at Insider Monkey.
